Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
It is not approved for human therapeutic use in Australia and is not for human or animal consumption
Orders are processed and shipped within 1 business day
A trial of 108 adults with obesity seeking treatment for alcohol use found that a once-weekly semaglutide injection reduced heavy drinking days in the past 30 days by an average of roughly 12 days, 50 per cent higher than the eight-day reduction seen in the placebo group
Published analyses have found peptide products contaminated with arsenic and lead at 10x acceptable limits, bacterial endotoxins, wrong amino acid sequences, and purity as low as 5-75%
Sconsigliato in gravidanza o durante l'allattamento
